EU Urges Sponsors To Assess COVID-19 Impact Before Starting New Trials
New Survey Shows Pandemic Is Negatively Impacting Patient Enrollment
New EU guidance on managing clinical trials in the context of COVID-19 requires sponsors to critically assess the feasibility of starting a new clinical trial or including new participants in an ongoing trial. A separate survey indicates that patient willingness to participate in new trials has dramatically declined due to the pandemic.
